GT Biopharma Reports Third Quarter 2024 Financial Results

Go back to GT Biopharma Reports Third Quarter 2024 Financial Results
(NASDAQ: GTBP) Delayed: 6.10 --0 (-0%)
Previous Close $6.10    52 Week High $ 
Open $6.10    52 Week Low $ 
Day High $6.10    P/E N/A 
Day Low $6.10    EPS $ 
Volume 217